Celularity Receives U.S. Food And Drug Administration (FDA) Preliminary Assessment For Celularity's Investigational Fuse Bone Void Filler To Be Regulated As A Device By FDA's Center For Devices And Radiological Health
Celularity’s Pre-Request for Designation is based on data demonstrating 100 percent biochemical characterization of the product Celularity intends to submit 510 pre-market notification to the... | April 3, 2023
Source: marketscreener.com